Multiplex Biomarker Imaging Global Market Report 2024

Description

Multiplex biomarker imaging is a technique that enables the simultaneous detection and analysis of multiple biomarkers within a single sample. This approach allows for the visualization of complex biological processes and molecular profiles. Advanced imaging technologies are used to map the spatial distribution of biomarkers within tissues, providing detailed insights into cellular interactions and microenvironments.

The main components of multiplex biomarker imaging include instruments, software, and services. Instruments are tools or devices used for specific scientific tasks or for making measurements such as speed, height, or sound. Imaging techniques used in this context include immuno fluorescence (IF) assay, tissue microarray (TMA) assay, immunohistochemistry (IHC) assay, fluorescent in situ hybridization (FISH) assay, and toponome imaging system (TIS). These techniques find applications in areas such as drug safety, oncology studies, and genetic characterization studies. End users of multiplex biomarker imaging include research institutes (government and private), clinical labs, pharmaceutical companies, and biotechnology firms.

The multiplex biomarker imaging market research report is one of a series of new reports from The Business Research Company that provides multiplex biomarker imaging market statistics, including the multiplex biomarker imaging industry global market size, regional shares, competitors with the multiplex biomarker imaging market share, detailed multiplex biomarker imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the multiplex biomarker imaging industry. These multiplex biomarker imaging market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The multiplex biomarker imaging market size has grown rapidly in recent years. It will grow from $0.44 billion in 2023 to $0.49 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to several factors, including the high incidence of cancer, the demand for precise diagnostic tools, the increasing prevalence of chronic diseases, the aging population, and the shift towards personalized medicine.

The multiplex biomarker imaging market size is expected to see rapid growth in the next few years. It will grow to $0.74 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to an increasing emphasis on personalized medicine, heightened research and development activities, a rise in clinical trials, the necessity for high-throughput screening methods in drug discovery, and supportive regulatory frameworks and guidelines. Major trends expected during this period include technological advancements, innovations in imaging technologies, advances in digital pathology, developments in data analysis and imaging software, and the integration of AI and machine learning with imaging technologies.

The increasing prevalence of chronic diseases is expected to drive the growth of the multiplex biomarker imaging market in the coming years. Chronic diseases are enduring health conditions that persist or recur over time, often with complex origins, multiple risk factors, and extended latency periods. The rising prevalence of chronic diseases can be attributed to various factors, including the rapid aging of populations, improved disease detection methods, better disease treatment and management, and changes in lifestyle and environmental risk factors. Multiplex biomarker imaging plays a vital role in managing chronic diseases by enabling comprehensive analysis and characterization of disease progression and response to treatment. For instance, a report published by the National Institutes of Health (NIH) in January 2023 projected a 99.5% increase in the number of individuals aged 50 and older with at least one chronic illness, from 71.52 million in 2020 to 142.66 million in 2050. Hence, the growing prevalence of chronic diseases is fueling the expansion of the multiplex biomarker imaging market.

Major players in the multiplex biomarker imaging market are focusing on offering innovative solutions, such as automated slide loaders, to deliver advanced imaging capabilities and enhance customer experience. Automated slide loaders streamline sample handling, reducing manual effort and improving throughput, which is crucial for conducting high-volume multiplex biomarker imaging experiments. For example, Standard BioTools Inc., a US-based provider of analytical systems and instruments, introduced the Hyperion XTi Imaging System in April 2024, featuring a new high-throughput multiplexed whole slide with added automation and flexibility. This system offers three modes for rapid analysis-preview, tissue, and cell modes-enabling researchers to quickly visualize tissue heterogeneity and conduct in-depth analysis. The novel whole slide imaging approach using imaging mass cytometry (IMC) provides up to 10 times higher throughput compared to cyclic immunofluorescent imaging. Additionally, the inclusion of an automated slide loader streamlines high-throughput imaging, reducing manual effort and ensuring standardization. These innovations aim to expedite breakthroughs in spatial proteomics, providing reliable insights into health and disease.

In March 2024, Calyx, a UK-based provider of medical imaging services, merged with Invicro to create a global leader in medical imaging and software solutions. This merger brings together expertise in medical imaging and software to offer enhanced support to customers in the biopharma industry, ranging from large pharmaceutical companies to specialized biotech firms. The merger between Calyx and Invicro, a US-based next-generation quantitative imaging biomarker company, creates a differentiated industry leader and addresses growing customer needs for comprehensive support.

Major companies operating in the multiplex biomarker imaging market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher corporation, Becton Dickinson and Company (BD), Carl Zeiss AG, Illumina Inc, PerkinElmer Inc., Bio-Rad Laboratories Inc, Bruker Corporation, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Abcam Plc, Meso Scale Diagnostics LLC, Fluidigm Corporation, NanoString Technologies, Quanterix Corporation, Akoya Biosciences, Enzo Biochem Inc, Cisbio Bioassays, Flagship Biosciences, Aushon BioSystems Ltd, Ionpath Inc., Biosims Technologies

North America was the largest region in the multiplex biomarker imaging market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex biomarker imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex biomarker imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The multiplex biomarker imaging market consists of revenues earned by entities by providing services such as imaging and analysis services, pathology services, and clinical and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The multiplex biomarker imaging market also includes sales of imaging instruments, reagents and kits, software, and analysis tools that are used in providing multiplex biomarker imaging services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex Biomarker Imaging Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiplex biomarker imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex biomarker imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiplex biomarker imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Component Type: Instruments; Software; Services
2) By Imaging Techniques: Immuno Fluorescence (IF) Assay; Tissue Microarray (TMA) Assay; Immunohistochemistry (IHC) Assay; Fluorescent In The Situ Hybridization (FISH) Assay; Toponome Imaging System (TIS)
3) By Application: Drug Safety; Oncology Studies; Genetic Characterization Studies
4) By End User: Research Institutes Government And Private; Clinical Labs; Pharmaceutical And Biotechnology
Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; Danaher corporation; Becton Dickinson and Company (BD); Carl Zeiss AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18678

1. Executive Summary

2. Multiplex Biomarker Imaging Market Characteristics

3. Multiplex Biomarker Imaging Market Trends And Strategies

4. Multiplex Biomarker Imaging Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Multiplex Biomarker Imaging Market Size and Growth

5.1. Global Multiplex Biomarker Imaging Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Multiplex Biomarker Imaging Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Multiplex Biomarker Imaging Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Multiplex Biomarker Imaging Market Segmentation

6.1. Global Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Instruments
Software
Services
6.2. Global Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Immuno Fluorescence (IF) Assay
Tissue Microarray (TMA) Assay
Immunohistochemistry (IHC) Assay
Fluorescent In The Situ Hybridization (FISH) Assay
Toponome Imaging System (TIS)
6.3. Global Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug Safety
Oncology Studies
Genetic Characterization Studies
6.4. Global Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Research Institutes Government And Private
Clinical Labs
Pharmaceutical And Biotechnology

7. Multiplex Biomarker Imaging Market Regional And Country Analysis

7.1. Global Multiplex Biomarker Imaging Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Multiplex Biomarker Imaging Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Multiplex Biomarker Imaging Market

8.1. Asia-Pacific Multiplex Biomarker Imaging Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Multiplex Biomarker Imaging Market

9.1. China Multiplex Biomarker Imaging Market Overview
9.2. China Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Multiplex Biomarker Imaging Market

10.1. India Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Multiplex Biomarker Imaging Market

11.1. Japan Multiplex Biomarker Imaging Market Overview
11.2. Japan Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Multiplex Biomarker Imaging Market

12.1. Australia Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Multiplex Biomarker Imaging Market

13.1. Indonesia Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Multiplex Biomarker Imaging Market

14.1. South Korea Multiplex Biomarker Imaging Market Overview
14.2. South Korea Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Multiplex Biomarker Imaging Market

15.1. Western Europe Multiplex Biomarker Imaging Market Overview
15.2. Western Europe Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Multiplex Biomarker Imaging Market

16.1. UK Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Multiplex Biomarker Imaging Market

17.1. Germany Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Multiplex Biomarker Imaging Market

18.1. France Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Multiplex Biomarker Imaging Market

19.1. Italy Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Multiplex Biomarker Imaging Market

20.1. Spain Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Multiplex Biomarker Imaging Market

21.1. Eastern Europe Multiplex Biomarker Imaging Market Overview
21.2. Eastern Europe Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Multiplex Biomarker Imaging Market

22.1. Russia Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Multiplex Biomarker Imaging Market

23.1. North America Multiplex Biomarker Imaging Market Overview
23.2. North America Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Multiplex Biomarker Imaging Market

24.1. USA Multiplex Biomarker Imaging Market Overview
24.2. USA Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Multiplex Biomarker Imaging Market

25.1. Canada Multiplex Biomarker Imaging Market Overview
25.2. Canada Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Multiplex Biomarker Imaging Market

26.1. South America Multiplex Biomarker Imaging Market Overview
26.2. South America Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Multiplex Biomarker Imaging Market

27.1. Brazil Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Multiplex Biomarker Imaging Market

28.1. Middle East Multiplex Biomarker Imaging Market Overview
28.2. Middle East Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Multiplex Biomarker Imaging Market

29.1. Africa Multiplex Biomarker Imaging Market Overview
29.2. Africa Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Multiplex Biomarker Imaging Market Competitive Landscape And Company Profiles

30.1. Multiplex Biomarker Imaging Market Competitive Landscape
30.2. Multiplex Biomarker Imaging Market Company Profiles
- 30.2.1. Merck KGaA
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Thermo Fisher Scientific Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Danaher Corporation
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Becton Dickinson and Company (BD)
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Carl Zeiss AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Multiplex Biomarker Imaging Market Other Major And Innovative Companies

31.1. Illumina Inc
31.2. PerkinElmer Inc.
31.3. Bio-Rad Laboratories Inc
31.4. Bruker Corporation
31.5. Bio-Techne Corporation
31.6. Leica Biosystems Nussloch GmbH
31.7. Abcam Plc
31.8. Meso Scale Diagnostics LLC
31.9. Fluidigm Corporation
31.10. NanoString Technologies
31.11. Quanterix Corporation
31.12. Akoya Biosciences
31.13. Enzo Biochem Inc
31.14. Cisbio Bioassays
31.15. Flagship Biosciences

32. Global Multiplex Biomarker Imaging Market Competitive Benchmarking

33. Global Multiplex Biomarker Imaging Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Multiplex Biomarker Imaging Market

35. Multiplex Biomarker Imaging Market Future Outlook and Potential Analysis

35.1 Multiplex Biomarker Imaging Market In 2028 - Countries Offering Most New Opportunities
35.2 Multiplex Biomarker Imaging Market In 2028 - Segments Offering Most New Opportunities
35.3 Multiplex Biomarker Imaging Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer